Navigating Early-Stage Biotech Challenges with Practical Expertise
MedSurgPI is pleased to share this edition of Practical Pointers, offering concise, actionable guidance for biopharmaceutical innovators and Medical Affairs professionals. This issue covers critical considerations in selecting contract manufacturing partners, explores the potential impact of FDA regulatory reform, addresses the responsible use of AI in scientific content generation, and highlights how Medical Affairs can optimize real-world evidence generation to support product value and patient outcomes.
Whether you’re advancing toward IND submission or building your value story post-approval, these insights are designed to support sound decision-making across the product development lifecycle.
For more information or to contact us: medsurgpi.com /